INDIANAPOLIS, March 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that preclinical data for agents targeting SMARCA2 (BRM) and multiple KRAS mutations will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April...
Read More Details
Finally We wish PressBee provided you with enough information of ( Lilly announces details of presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting )
Also on site :
- Mel Owens' Ex-Wife Issues Bold Statement on His Upcoming 'Golden Bachelor' Season: 'It's Going to be Bad'
- Al menos 9 personas muertas y 15 heridas por caída de un autobús a un río en México
- European retailer inspired by ‘new Med’ hits major milestone opening its 50th store in the US – and 15 more are coming